Home

BiocommAI

MedicalGPT

MedicalGPT™ by BiocommAI™

BiocommAI™ is a precision medicine software business with an exclusive licence to provide MedicalGPT™ services to Biocomm users worldwide.

MedicalGPT™ is a state-of-the-art Generative AI system for personalized medicine learning and knowledge-sharing conversations, which is trained to follow an instruction or query in a prompt and provide a detailed and scientifically annotated response to the user.

BiocommAI™ is a Special Purpose Vehicle (SPV) subsidiary of Normax Biomed in Ireland.

Easy-to-use. Chat, just like that.

BiocommAI™ has developed and trained MedicalGPT™, a Generative AI system and ‘founcation model’ which interacts with patients, doctors and community members in a conversational way – similar to ChatGPT.

Generative AI for Precision Medicine

BiocommAI™ is optimizing MedicalGPT™ to support safe and informative dialogue between patients and doctors in vertical biocomm.net communities, with a specific disease focus, for the emerging field known as “precision medicine” with the free MedicalGPT™ service.

MedicalGPT™ is an artificial intelligence large language model (“LLM”) based on generative pre-trained transformer (“GPT”) technology.

Peer-reviewed Medical & Scientific GPT Training

BiocommAI™ generative AI content is trained on an indexed database of more than 100 million scientific and medical journal articles for output of personalized conversational content with annotated references for patients and doctors.

Transformative for Patients and Doctors

MedicalGPT™ can be a useful tool for patients to learn more about their specific condition of interest and to support doctors with fast and accurate medical search information annotated with relevant peer-reviewed medical and scientific report sources.

MedicalGPT™ is a machine learning neural network systems and technology also known as “deep learning AI” which can increase effectivemenss and accuracy over time by ‘learning’ from Biocomm user data input and response.

Community Knowledge: Chat. Learn. Connect. Share.

The dialogue format of MedicalGPT™ makes it possible to answer follow-up questions, reference the conversation and support patients and doctors and communities in a dynamic and easy to understand computer user interface – chat, learn, connect and share community knowledge.

Exclusive synergy with Biocomm

MedicalGPT™ is integrated with biocomm.net service for patients and doctors who may opt-in to use BiocommAI™ for anonymous, HIPAA and GDPR compliant, educational and knowledge-sharing purposes only.

Exclusive Data Licence

BiocommAI™ has an exclusive licence to biocomm.net anonymized vertical medical content for GPT model training purposes, for MedicalGPT™, with HIPAA and GDPR data compliance.

LEADERSHIP TEAM

(262 Years experience)

Peter Jensen MFA BSc

CEO & Chairman. Founder.

  • 42 Years CEO & entrepreneur
  • 38 Years Multimedia & Software industry
  • First Mobile App for Ericsson (1999)
0
Years of Experience

Martin Stevens FCA

Chief Financial Officer

  • Gjensidige Insurance
  • Finansbanken
  • Ernst & Young
  • Grant Thornton
  • Fokus Bank
  • Den norske
  • Nordea Bank
0
Years of Experience

Michal Hogarth MD FACMI, FACP

Chief Medical Officer and Clinical Bioinformatics

  • Prof. UC Davis
  • Prof. UC San Diego
  • Principal Investigator & Project Leader California Electronic Death Record System (CA-EDRS)
0
Years of Experience

Mitch Goldberg

Chief Technology Officer

  • Amazon (Retail AI)
  • Microsoft (22 years, Incl. AI Research, Cambridge, England)
0
Years of Experience

Lee Abell PhD

Chief Software Engineer

  • AI systems
  • Distributed Ledger Technology
  • HPC
  • Database
  • Simulation
  • Control Systems
0
Years of Experience

Ulf Wretling MSc MS

Chief Strategy Officer (CSO) and Strategic Partnerships

  • Sony Ericsson
  • Ericsson
  • Telia
  • Ellemtel Telecomm.
  • Camanio remote patient monitoring
0
Years of Experience

Sorin Rotariu

Country Manager Romania Software Development Teams

  • Visma, Romania
  • The Mobile Media Company, Romania
  • Software Teams 300+ headcount
0
Years of Experience

BOARD OF DIRECTORS

Peter Jensen MFA BSc

CEO & Chairman. Founder.

peter.jensen@biocomm.ai

+44 7985 513 860

Martin Stevens FCA

Chief Financial Officer (CFO) and Director

martin.stevens@biocomm.ai

+44 7985 513 860

David Wilson

Non-executive Director Subject to contract

info@seam.ventures

NED 1. by Waystone

Non-executive Director Launch on Demand

IMPORTANT DISCLAIMER

MedicalGPT™ is a service for knowledge sharing and educational purposes.

MedicalGPT™ is free and available to biocomm.net users: patients, doctors, scientists and impact investors.

MedicalGPT™ sometimes writes incorrect answers which can sound plausible.

MedicalGPT™ is NOT medical advice. Patients should always consult their doctor.

The Synergy of AI-safety and Bio-safety

BiocommAI Security

BiocommAI™ data is compliant with U.S. Health Insurance Portability and Accountability Act (HIPAA) and in compliance with the the General Data Protection Regulation (GDPR) of the European Union.

The MedicalGPT™ service runs on Google Cloud with the Google Kubernetes Engine (GKE) with the following security features:

  • Google Cloud is a SOC 2® Type 2 certified service.
  • MedicalGPT™ requires secure connections for all users (HTTPS TLS 1.2) and encrypt all data at rest.
  • MedicalGPT™ follows application security best practices.
  • BiocommAI™ hosts all data with Google Cloud, a leading cloud provider, with secure SSAE 16 audited data centers.
  • BiocommAI™ works with third-party security services and network scanning tools to reduce vulnerabilities and security threats to user data.

AI Safety Standards of BiocommAI

USER SAFETY. MedicalGPT™ standard safety features will include:

  • QUERIES. To avoid so-called GPT ‘hallicination’ on lengthy sessions, users can ask a maximum of 5 questions per session and 50 in total per day.
  • TRAINING DATA. User data for GPT training will be opt-in and anonymized.
  • USER DATA. User data will be managed with HIPAA and GDLR security compliance
  • SAFETY WARNING AND DISCLAIMERS will be prevalently displayed with data output from MedicalGPT™

AGI SAFETY. BiocommAI™ is committed to innovate with, to adhere to, and to support the most advanced Artificial General Intelligence (AGI) safety standards available to the industry and the AGI safety community, including strategic collaborations in development with leading AI safety organizations:

AI Safety Blog for Extreme Social Impact (ESI) by BiocommAI

FIRST DO NO HARM.

Learn More About Our Leading Sponsors and Partners

Normax aims to be a trusted guide for your journey to health and happiness and competitive financial returns via Normax financial products for mRNA vaccines and mRNA Vax Factories designed to fit most any risk return appetite, for professional investors only.

 

Normax Biomed Limited

Biocomm is social media for patients, their families and their doctors. Your personal community should be filled with what matters to you most: biomedical and healthcare issues important to you and your loved ones – the information, data and social sharing that can help you live a better life.

 

Biocomm Social Media for Good Limited

Get in touch!

We’re always looking for ideas on how to improve our service for our committed global social impact team. Contact us!

[contact-form-7 id=”5″ /]